Christiaan & Company

I’m honored to join the conversation at The Power of X Summit: Solutions for an Untapped Market to address the critical gaps in women’s health. March 24-25 in #NYC. We have the knowledge, the innovation, and the power to redefine what’s possible. Let’s tackle real solutions to get real investments and shape the future—together. See you there! #PowerOfX #wewillcure Anna Howell Seema Kumar WeWillCure.com Bullpen Likarda Kaida BioPharma Oral Biolife Inc. Agile Consulting Group (ACG)

Pitchers report to Bullpen Spring Training in Miami in one week! Secure your spot on the roster. Request an Invite: https://lnkd.in/gjjzchx2 Highlights: Investival Showcase - Comp’d Admission #Bullpen #PitchFest - Comp’d Admission Miami Happy Hours Virtual Pitch HQ: Hatch Fairhope See post for more details… See you there Bullpen! Cheryl Z., Sachin Bidani, Stephen Thesing, Gwen Fewell, Dov Kalton, Tim Glennon, KATRINA ROGERS, Jim Pollock, Scott Alpizar, James Zanewicz, JD, LLM, RTTP, Bryan Poltilove, Kenny Morand, Robert Neusner, Sofia Esteves Carvalho, Jeff Missling, Jess Hawthorne, Daniel Tabb, Shreefāl Mehta, Patrick Moran, Hitesh W., Jolly Nanda, MBA, John Pennett, Linda Ann Tempelman, Jenn Bonilla, PhD, Byron Haney, James F. Lynch (PhD, MBA), Karen Wu, Bill Mantzoutsos, MBA, Matt Takahashi, Zachary S. Brooks, PhD, EMBA, Harsha K Rajasimha, Joachim Bader, Caley Anderson, MBA, Rachel Satterlee, Keith Glines, Henryk Dabrowski

The inimitable biotech leader Behzad Mahdavi, Ph.D., MBA, NACD.DC has published a book that should be on your radar. MASTERING COMMERCIAL INNOVATION: CREATING PROFITABLE GROWTH FROM IDEAS In today’s rapidly evolving marketplace, businesses must embrace innovation to thrive and stay ahead of the competition. However, many companies struggle to identify untapped opportunities for innovation-based growth and profit. It looks like they could do with some help... In Mastering Commercial Innovation, a captivating book by industry veteran Behzad Mahdavi, Eng., Ph.D., MBA, we explore the concepts of successful commercial innovation through the story of Kevin, a charming and hard-working consultant on a mission to improve the bottom line of struggling companies across the world! Join Kevin on his journey as he works with national and international clients representing different industries to enhance the innovation culture and financial performance of their diverse companies while explaining the principles of commercial innovation in clear and simple language. Using this narrative approach, Dr. Mahdavi’s book provides guidance on the processes of commercial innovation, enabling readers to achieve their own profitable and sustainable success. This is enhanced by the interactive aspect of the book, where Dr. Mahdavi uses the breaks between chapters to invite contributions from his readers, which could be included in a future edition. Mastering Commercial Innovation is a must-read for business leaders, researchers, marketers, investors, MBA and Engineering students and anyone else interested in creating a culture of innovation and collaboration. Dr. Mahdavi offers practical guidance to build high-performance teams, foster a collaborative culture, and unleash the creative potential within organizations, providing the foundations for the next generation of innov-preneurs and innov-executives to drive sustainable growth and profit in their industries. By following the strategies outlined in this book, businesses can achieve sustainable growth and create a competitive edge in the market. Whether you’re new to the field or already a highly experienced innovator, you’ll enjoy following the story of Kevin as he juggles his commitments to friends, family and clients. Learning about Kevin’s life will unlock your innovative potential and help you to achieve greater success in today’s competitive business environment! Unearth the secrets of Mastering Commercial Innovation with Dr. Behzad Mahdavi, and embark on a transformative journey that will change the way you view innovation, profitability, and the path to enduring success.

#Bullpen #SpringTraining #Miami 🌴March 10 - 14☀️ Request an Invite: https://lnkd.in/gkq-ixvj Event Flier: https://lnkd.in/gsVxcwi9 It's that time of year again...Investment Season. Bullpen Spring Training is the regimen to get your strategy in shape whether you are an operator, investor, or advisor. Join us for Investival Showcase at the Miami Beach Convention Center for a premier Biotech, MedTech, and Digital Health networking event. Their cutting-edge platform connects innovators with investors and partners through exclusive 1:1 sessions. Bullpen Spring Training brings the Team together to prepare for Investment Season. BIO International Convention in Boston is right around the corner June 15 - 19. Get the reps you need...and maybe bring some funding home.   #Mantra | Find Someone to Help. Repeat. ⚾️Investival Showcase | Mar 10 & 11 Miami Beach Convention Center | Mon & Tues Member Comp Admission | $2K Value Member Pitch Discount | 20% Bullpen Investor Panels Bullpen Happy Hours Request Invite for Codes👆 ⚾️Virtual Pitches | Mar 12 - 14 #MedTech | Wed #Therapeutic | Thurs #Tools + #Services | Fri 10 Companies Each Day 10-min Main Room Pitch Breakout Room Q&A Curated Investor Audience Online Feedback Forms LinkedIn Promo Package Pitch 2 Peers | Mar 5 Request Invite to Pitch☝️q Thank you to our Supporters: Collaborative Drug Discovery - CDD Vault CSC Leasing Houchens Insurance Group Areca Financial Services VNTR BIO on the BAYOU Tulane University School of Medicine The Alliance for Artificial Intelligence in Healthcare (AAIH) Nucleate Florida About Bullpen: Bullpen is an invite-only Club gathering Life Science Dealmakers with the shared goal of helping each other. We prepare for and attend premier Life Science events together including JPM Week and BIO International Convention. Our semi-weekly Virtual Master Panels foster connections that flourish at our regional events. Our in-person events are unrivaled experiences with an unmatched community. Bullpen seeks leaders who live by our mantra and wish to grow authentic connections with like-minded leaders. Our 3000+ Members represent public and private companies, funds, offices, strategics, bankers, brokers, agencies, accelerators, studios, associations, non-profits, institutions and other critical entities. Connect with an inimitable Club to ignite your life science ventures. Membership: https://lnkd.in/gfnyBEpK Mission: https://lnkd.in/gemP3WGC Schedule: https://lnkd.in/giP5dNkR Team: https://lnkd.in/gV8C4XRK

Springbok Analytics Muscles $5M Series A Springbok's AI-Powered Muscle Analytics Is Advancing Precision Medicine, Elite Sports Performance, and Longevity on a Global Scale Full Article: https://lnkd.in/g3TjuT-9 CHARLOTTESVILLE, Va., Jan. 24, 2025 /PRNewswire/ - Springbok Analytics (www.springbokanalytics.com), a leader in AI-driven muscle analytics, today announced the close of an oversubscribed $5M Series A funding round. The round was led by Transition Equity Partners, with participation from the National Basketball Association (NBA), Cartan Capital, Boston Global Group and other strategic investors. This funding supports Springbok's mission to advance muscle health analysis across human performance, life sciences, and longevity. "The successful completion of our Series A funding is a significant milestone for Springbok Analytics, reflecting our team's singular focus on establishing the standard of care for muscle health and the growing recognition of our technology's potential," said Springbok Analytics CEO and Co-Founder Scott Magargee. Springbok Analytics has developed a first-of-its-kind, FDA-cleared AI technology that delivers automated, precise and comprehensive muscle health assessments from MRI scans. "Our Series A funding will allow us to expand our reach and continue driving innovation," said Silvia Blemker, Co-Founder and Chief Scientific Officer of Springbok Analytics. "Transition Equity Partners is proud to be a strong and early supporter of Springbok Analytics, having led the company's seed round, and now strengthening the partnership in leading this Series A round," said Patrick Eilers, Managing Partner & Founder of TEP. "Springbok Analytics represents exactly the kind of visionary company that Cartan Capital is proud to support," said CiCi Bellis, Founder and Managing Partner of Cartan Capital. Springbok's other strategic investors include: TitletownTech Anthropy Partners, LLC Getty Performance Scienc CAV Angels Alumni Ventures Driving Innovation Across Life Sciences, Sports, and Longevity Springbok's platform is advancing multiple fields. In life sciences, it enhances clinical trials and research aimed at improving therapies for musculoskeletal conditions. For elite sports, it provides athletes and trainers with precise, data-driven insights to optimize performance and recovery. The company is also addressing the growing demand for longevity solutions, equipping individuals with actionable insights to better manage muscle health as they age. Full Court Capital LLC, a boutique investment bank focused on sports and human performance technology, served as financial advisor to Springbok Analytics for the Series A. For more information about Springbok Analytics or to book your own scan, visit www.springbokanalytics.com.

One of the keys to cutting the cost of drugs in the United States is to raise their cost in other countries, Eli Lilly CEO David Ricks said Tuesday in an interview at the Economic Club of Washington, D.C. “We have to raise developed countries, what they pay, and we can lower the U.S.,” Ricks said. “I think that’s a policy argument we’ll hear about soon with the new administration.” Over the last few years, President Joe Biden’s Inflation Reduction Act—and specifically its Medicare price negotiations—have been a point of contention between the industry and the government. There hasn’t been much clarity on how Trump will approach drug costs. He has threatened to roll back parts of the IRA but he could also consider accelerating or expanding the price negotiations, according to S&P Global in a recent report, citing “bi-partisan support for lowering drug spending and his earlier expressed support for Medicare drug pricing negotiation.”

As we reflect on what we're thankful for this season, we want to take a moment to express our deep gratitude to Jess Hawthorne and CSC Leasing for their ongoing partnership and invaluable support of the Bullpen community. Jess has been a true leader in how he consistently empowers businesses to overcome capital barriers and thrive. From early-stage startups to established enterprises, CSC Leasing continues to provide critical, non-dilutive financing solutions that help companies grow without sacrificing equity. "Lease your equipment. Own your growth." It's more than just a motto—it’s a testament to their commitment to helping businesses, large and small, scale sustainably and efficiently. We're grateful to have partners like Jess and CSC Leasing by our side.

Congratulations Tamika Jackson and The Beautiful Way Foundation on a vibrant and successful kickoff at Portal Innovations, LLC Boston. The people and topics were fantastic and I learned so much about creating equity in clinical trials. Thank you to Lynn Fischer and KMAK Capital for your fundamental support and true leadership in helping to launch this.

First task: Curing #diabetes. Solving oxygenation and immune challenges for stem cells brought together @Giner Inc.’s Linda Tempelman, Cornell University’s Minglin Ma and colleagues to form Persista Bio Inc. Check out the potential impact at our newly launched website! 🎈 👉 Link in comments Let us know what you think about the new site! #biotech #diabetesresearch #stemcells

Check out this interview with our CEO, Chris Seibert at BIO International in San Diego.